Free Trial

Andlauer Healthcare Group (TSE:AND) Trading Down 0% - Should You Sell?

Andlauer Healthcare Group logo with Industrials background

Key Points

  • Andlauer Healthcare Group's shares experienced no change, closing at C$53.32 with a trading volume significantly down by 58% compared to its average.
  • The company's market capitalization stands at C$2.09 billion with a P/E ratio of 31.36, indicating a relatively high valuation.
  • Andlauer operates primarily in Specialized Transportation and Healthcare Logistics, generating most of its revenue from providing temperature-controlled services to healthcare clients.
  • MarketBeat previews top five stocks to own in November.

Andlauer Healthcare Group Inc. (TSE:AND - Get Free Report)'s share price dropped 0% during trading on Thursday . The company traded as low as C$53.23 and last traded at C$53.32. Approximately 29,358 shares were traded during mid-day trading, a decline of 58% from the average daily volume of 69,575 shares. The stock had previously closed at C$53.34.

Andlauer Healthcare Group Trading Up 0.6%

The company has a market cap of C$2.10 billion, a price-to-earnings ratio of 31.51 and a beta of 0.75. The company has a debt-to-equity ratio of 39.31, a current ratio of 1.44 and a quick ratio of 1.66. The firm's fifty day moving average price is C$53.28 and its 200-day moving average price is C$49.45.

About Andlauer Healthcare Group

(Get Free Report)

Andlauer Healthcare Group Inc is an investment holding company. It operates in two segments namely Specialized Transportation and Healthcare Logistics. The company generates maximum revenue from the Specialized Transportation segment. Its Specialized Transportation segment provides specialized temperature controlled services to healthcare customers.

Featured Articles

Should You Invest $1,000 in Andlauer Healthcare Group Right Now?

Before you consider Andlauer Healthcare Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Andlauer Healthcare Group wasn't on the list.

While Andlauer Healthcare Group currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report
Like this article? Share it with a colleague.